Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Renard

Showing results (191-200 of 225) with videos related to

Pageof 23
Sort By:
Diabetes Care|June 27, 2013
Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreasBoris P Kovatchev, Eric Renard, Claudio Cobelli, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 28, 2022
Hypo-METRICS: Hypoglycaemia-MEasurement, ThResholds and ImpaCtS-A multi-country clinical study to define the optimal threshold and duration of sensor-detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health economic outcomes: The study protocolPatrick Divilly, Natalie Zaremba, Zeinab Mahmoudi, et al.
Cell Metabolism|April 10, 2009
CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistanceCarine Chavey, Gwendal Lazennec, Sylviane Lagarrigue, et al.
Journal of Diabetes Science and Technology|July 1, 2025
Evolution of the Artificial Pancreas: Components and Integration-CGMs, Insulin, and AP SystemsRichard M Bergenstal, Adam Heller, Marc D Breton, et al.
Diabetes Technology & Therapeutics|January 17, 2019
The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component InteroperabilityStacey M Anderson, Eyal Dassau, Dan Raghinaru, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 29, 2026
Exploring the gap between sensor-detected (SDH) and person-reported hypoglycaemia (PRH): The voice of people living with diabetesMonika Cigler, Omaima El-Hakouni, Renald Mecani, et al.
Diabetes, Obesity & Metabolism|November 25, 2025
A nationwide 12-month observatory of automated insulin delivery shows improved glucose control, sustained adoption, and reduced acute severe eventsJean-Pierre Riveline, Jean-Baptiste Julla, Elisabeth Bonnemaison, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 7, 2021
Ten-year outcomes of islet transplantation in patients with type 1 diabetes: Data from the Swiss-French GRAGIL networkSandrine Lablanche, Sophie Borot, Anne Wojtusciszyn, et al.
The Lancet. Digital Health|December 16, 2020
Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trialPierre-Yves Benhamou, Sylvia Franc, Yves Reznik, et al.
Diabetologia|July 30, 2024
The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS appUffe Søholm, Melanie Broadley, Natalie Zaremba, et al.
Pageof 23

Showing results (191-200 of 225) with videos related to

Sort By:
Pageof 23
Diabetes Care|June 27, 2013
Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreasBoris P Kovatchev, Eric Renard, Claudio Cobelli, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 28, 2022
Hypo-METRICS: Hypoglycaemia-MEasurement, ThResholds and ImpaCtS-A multi-country clinical study to define the optimal threshold and duration of sensor-detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health economic outcomes: The study protocolPatrick Divilly, Natalie Zaremba, Zeinab Mahmoudi, et al.
Cell Metabolism|April 10, 2009
CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistanceCarine Chavey, Gwendal Lazennec, Sylviane Lagarrigue, et al.
Journal of Diabetes Science and Technology|July 1, 2025
Evolution of the Artificial Pancreas: Components and Integration-CGMs, Insulin, and AP SystemsRichard M Bergenstal, Adam Heller, Marc D Breton, et al.
Diabetes Technology & Therapeutics|January 17, 2019
The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component InteroperabilityStacey M Anderson, Eyal Dassau, Dan Raghinaru, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 29, 2026
Exploring the gap between sensor-detected (SDH) and person-reported hypoglycaemia (PRH): The voice of people living with diabetesMonika Cigler, Omaima El-Hakouni, Renald Mecani, et al.
Diabetes, Obesity & Metabolism|November 25, 2025
A nationwide 12-month observatory of automated insulin delivery shows improved glucose control, sustained adoption, and reduced acute severe eventsJean-Pierre Riveline, Jean-Baptiste Julla, Elisabeth Bonnemaison, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 7, 2021
Ten-year outcomes of islet transplantation in patients with type 1 diabetes: Data from the Swiss-French GRAGIL networkSandrine Lablanche, Sophie Borot, Anne Wojtusciszyn, et al.
The Lancet. Digital Health|December 16, 2020
Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trialPierre-Yves Benhamou, Sylvia Franc, Yves Reznik, et al.
Diabetologia|July 30, 2024
The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS appUffe Søholm, Melanie Broadley, Natalie Zaremba, et al.
Pageof 23